Cholinesterase Inhibitors for Alzheimer Disease: Do They Provide More Than Symptomatic Benefits?-Reference-Cited by-同舟云学术

Cholinesterase Inhibitors for Alzheimer Disease: Do They Provide More Than Symptomatic Benefits?

Published:2011-03 Issue:3 Volume:19 Page:266-273
ISSN:1064-7481
Container-title:The American Journal of Geriatric Psychiatry
language:en
Short-container-title:The American Journal of Geriatric Psychiatry

Author:

Suh Guk-Hee,Ryu Seung-Ho,Lee Dong-Woo,Han Changsu,Ju Young-Su,Kee Baik Seok,Lee Joon-Noh,Bae Jae Nam,Choi Jong-Hyuk,Kim Dai-Jin,Lee Nam-Jin,Lee Jun-Young,Go Hyo-Jin,Yi Jung-Seo,Cho Seong-Jin,Jeon Yang-Whan

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Reference23 articles.

1. The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial;Raskind;Arch Neurol,2004

2. Open-label, multi-center, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease;Doody;Arch Neurol,2001

3. Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy;Wallin;Dement Geriatr Cogn Disord,2004

4. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease;Krishnan;Am J Psychiatry,2003

5. Cholinesterase inhibitor treatment alters the natural history of Alzeimer's disease;Lopez;J Neurol Neurosurg Psychiatry,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials;Neurology;2022-09-12

2. Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study;The British Journal of Psychiatry;2018-02-28

3. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena;Biochimie;2015-04

4. Risk of Death Among Persons with Alzheimer's Disease: A National Register-Based Nested Case-Control Study;Journal of Alzheimer's Disease;2012-12-03

5. Improving Alzheimer's disease phase II clinical trials;Alzheimer's & Dementia;2012-11-19